This study investigated the role of NR5A2 (nuclear receptor subfamily 5 group A member 2) in regulating inflammation and cell proliferation via the NF-κB pathway in the context of polycystic ovary syndrome (PCOS) with polyendocrine metabolic features.
NR5A2 was found to increase inflammation and cell proliferation through activation of the nuclear factor κB (NF-κB) signaling pathway in PCOS, suggesting it acts as a pro-inflammatory and proliferative driver in this condition.
The paper was published only days before the extraction date; full methodological details (e.g., sample size, in vitro vs. in vivo models, human vs. animal data) are not available from the provided metadata alone, limiting critical appraisal.
NR5A2 and the NF-κB pathway may represent novel therapeutic targets in PCOS with metabolic and inflammatory features, though clinical translation requires further study.
Explore related topics
